Consideration for Biomarker Development When Optimizing Portfolios

Fri, May 14, 2025, 08:00 – 09:00AM (PDT), 11:00 – 12:00 noon (EST)

Speaker:

Zoran Antonijevic is the Chief Scientific Officer at Bioforum. He held executive positions in Pharmaceutical Companies and CROs and designed well over 100 clinical trials in numerous therapeutic areas, many of which included innovative designs. Zoran was a long- time Chair and leader of the DIA Innovative Design Scientific Working Group. He has authored numerous papers, scientific presentations, courses and trainings, and was editor of books “Optimization of Pharmaceutical R&D Programs and Portfolios” and, together with Bob Beckman, “Platform Trials in Drug Development”.

Strategic Alliance: